| Ralph J Mack, MD | |
|
1201 S Miller St Ste A, Wenatchee, WA 98801-3201 | |
| (509) 663-8711 | |
| Not Available |
| Full Name | Ralph J Mack |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 1201 S Miller St Ste A, Wenatchee, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124044128 | NPI | - | NPPES |
| P01256589 | Other | WA | RR MEDICARE WVH |
| 1124044128 | Medicaid | WA | |
| 315795 | Other | WA | WVH LNI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD00023729 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ralph J Mack, MD 820 N Chelan Ave, Wenatchee, WA 98801-2028 Ph: (509) 663-8711 | Ralph J Mack, MD 1201 S Miller St Ste A, Wenatchee, WA 98801-3201 Ph: (509) 663-8711 |
News Archive
Yissum Research and Development Company of the Hebrew University of Jerusalem, the technology transfer company of the Hebrew University, announced today the inception of its subsidiary, Integra Holdings, a holding company focusing on biopharmaceutical companies based on inventions of researchers from the Hebrew University.
Oncology drug advertisements that ran in patient-focused cancer magazines presented the drugs' benefits differently - earlier in the advertisement text and in larger type size - than their side effects or risks, according to an analysis by researchers at Dana-Farber Cancer Institute in Boston.
Using immature stem cells to create a miniature model of the gut in the laboratory, researchers at Washington University School of Medicine in St. Louis and the University of Pittsburgh have determined how infection-causing enteroviruses enter the intestine.
Two research teams led by Dr. Christine Des Rosiers and Dr. John D. Rioux, both researchers at the Montreal Heart Institute (MHI) and professors at the Universit- de Montr-al, have been awarded grants of $2.5 million and $2.3 million, respectively, to finance research projects on genetics and genomic medicine.
Creabilis, a late clinical stage European dermatology company with a focus on pruritus (itch), today announces it has treated the first patients in its Phase 2b study of its lead product, CT327, in patients with atopic dermatitis.
› Verified 1 days ago
Dr. Ahmad Sabih Musmar, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 933 Red Apple Rd, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Jonathan Andrew Bolles, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1201 S Miller St Ste A, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Brett J. Hiendlmayr, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-662-1511 | |
Kevin Joseph Struzzieri, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1201 S Miller St, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Dr. Brent A. Barber, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 933 Red Apple Rd, Wenatchee, WA 98801 Phone: 509-663-8711 | |
Mircea Batanoiu, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 820 N Chelan Ave, Wenatchee, WA 98801 Phone: 509-663-8711 Fax: 509-665-6065 | |
Dr. Mark Douglas Johnson, M.D., MTM&H Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 933 Red Apple Rd, Wenatchee, WA 98801 Phone: 509-665-6210 Fax: 509-667-3310 |